Edition:
United States

Blueprint Medicines Corp (BPMC.OQ)

BPMC.OQ on NASDAQ Stock Exchange Global Select Market

56.28USD
1:52pm EST
Change (% chg)

$-1.62 (-2.80%)
Prev Close
$57.90
Open
$58.24
Day's High
$58.24
Day's Low
$55.75
Volume
36,948
Avg. Vol
121,633
52-wk High
$108.62
52-wk Low
$50.51

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 1.10 -1.656
Jun '18 41.44 -0.617
Mar '18 0.95 -1.294
FY 2017 Dec '17 1.63 -1.225
Sep '17 8.07 -0.964
Jun '17 5.89 -0.862
Mar '17 5.84 -0.843
FY 2016 Dec '16 7.69 -0.747
Sep '16 6.16 -0.618
Jun '16 7.07 -0.695
Mar '16 6.86 -0.572
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 8 1.68 3.40 1.00 3.61
Quarter Ending Mar-19 6 2.00 5.00 1.00 --
Year Ending Dec-18 9 45.21 46.90 44.50 13.88
Year Ending Dec-19 9 6.63 20.00 0.00 14.90
Earnings (per share)
Quarter Ending Dec-18 9 -1.71 -1.30 -1.90 -1.19
Quarter Ending Mar-19 7 -1.79 -1.41 -2.16 --
Year Ending Dec-18 9 -5.28 -4.86 -5.48 -4.82
Year Ending Dec-19 9 -7.61 -5.98 -9.35 -5.28
LT Growth Rate (%) 1 34.00 34.00 34.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 101.33 49.58 6.22
Price to Book (MRQ) 6.92 10.17 5.20
Price to Tangible Book (MRQ) 6.93 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions -- 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -16.63 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago 16.37 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -23.91 75.90 23.08
EPS (TTM) vs TTM 1 Yr. Ago -32.61 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 13.07 3.44 3.10
LT Debt to Equity (MRQ) 0.18 18.69 11.49
Total Debt to Equity (MRQ) 0.71 31.36 16.03
Interest Coverage (TTM) -103.52 -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -387.82 -- --
EBITD - 5 Yr. Avg -- -109.98 13.16
Operating Margin (TTM) -394.04 -185.00 6.07
Operating Margin - 5 Yr. Avg. -- -126.42 8.47
Pre-Tax Margin (TTM) -388.91 -175.77 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.58 8.71
Net Profit Margin (TTM) -388.91 -182.51 3.12
Net Profit Margin - 5 Yr. Avg. -- -136.98 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 241,330 7,649,006 873,053,182
Net Income/Employee (TTM) -938,547 653,334 103,483,965
Receivable Turnover (TTM) 7.96 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.08 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -31.52 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -34.88 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -40.89 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.41 17.37
  1 Year 3 Year 5 Year
Sales % 143.61 -- --
EPS (TTM) % 14.01 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Blueprint Medicines Corp

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 26.74 22.37 99 98
13 Week 24.13 18.08 99 94
26 Week 48.03 36.78 99 98
52 Week 147.42 109.71 99 68
YTD 136.22 107.45 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 262
Total Shares Held: 44,909,368
3 Mo. Net Change: -512,551
# New Positions: 37
# Closed Positions: 33
# Increased Positions: 120
# Reduced Positions: 112
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.